Skip to content
Business Times – Lifestyle
Author:
DELFI Diagnostics
DELFI Diagnostics Receives New York State Department of Health Clinical Laboratory Permit, Completing Authorization to Serve Health Systems Across All 50 States
May 28, 2026
DELFI Diagnostics to Present First Clinical Utility Data for Blood-Based Lung Cancer Screening at ATS 2026 International Conference
May 13, 2026
DELFI Diagnostics Appoints Charles Newton to Board of Directors
April 29, 2026
DELFI Diagnostics to Showcase Whole-Genome cfDNA Platform Advances in Cancer Detection and Monitoring at AACR 2026 Annual Meeting
April 6, 2026